Coal is far from a favorite fuel these days, despite its abundance. No matter how much we scrub it, we simply can't make it turn green. That being said, the world still uses a whole lot of coal. In fact, over the past 10 years, coal consumption has grown by an average of 4.4% annually, making it the fastest-growing fossil fuel.
According to BP's "Statistical Review of World Energy 2013," last year China accounted for 50.2% of global coal consumption. Overall, the Middle Kingdom used 1,873.3 million tonnes oil equivalent of coal. For perspective, the U.S. used 437.8 million tonnes oil equivalent last year, which was just 11.7% of the world's total and a drop of 11.9% year over year. Both countries are larger coal customers than�Santa Claus, as it's estimated that the big guy gives out only about 10,000 tons of coal each year to children who misbehave.�
Going back to China's dominance of the coal market, last year its consumption grew by 6.1%, while demand across the rest of the world declined by 4.2%. That meant China accounted for all of the net growth in global coal consumption last year. That means the coal industry is seriously at risk if China's growth slows down, which is why investors need to watch it very closely.
Best India Stocks To Invest In Right Now: Medbox Inc (MDBX.PK)
Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs. The system also allows these clinics to demonstrate that the user visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. The Company has national and international presence with offices in Los Angeles, New York, Toronto, London and Tokyo.
Medbox, through its subsidiaries, offers consulting services to the alternative medicine industry, as well as to the mini self-storage market. The Company provides consulting services primarily to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning th e availability of alternative medicines, as well as existing jurisdictions, nationwide.Advisors' Opinion:
- [By Alan Brochstein]
Taking into account all of the data I have shared, I want to introduce my take on the most important names to follow. My initial list takes into account not only the market cap, but also business model and interest level. These are the stocks that I think merit the most attention (in alphabetical order):CannaVest (CANV.OB)GW Pharma (GWPH)MedBox (MDBX.PK)Medical Marijuana, Inc. (MJNA.PK)
CANV doesn't really trade, as it is held closely by insiders (99.7%, including MJNA). I have a few concerns, including the valuation and some near-term financial challenges typical of a start-up with just one client looking to expand its customer base, but I like the focus and the fact that it is an SEC filer with a relatively clean history (i.e. none of the baggage of some of these other companies). I have spoken to its outsourced CFO and am impressed by his background (has been CFO or held key financial roles at publicly-traded healthcare companies). CANV is the partner to MJNA that is responsible for manufacturing the CBD (Cannibidiol, the cannabinoid in marijuana that is increasingly viewed as offering substantial medical benefits). I am very concerned about the near-term financials, but this is a pure-play with probably a two-year lead over other companies. I don't see a moat in terms of intellectual property or brands, but they have a good lead in terms of sourcing of supply and penetration into potential customers. Quite simply, they don't appear to have competition at present. The company, then, is a call option on CBD demand taking off. It appears that it could be a supplier to even Big Pharma should medical marijuana research move into the mainstream.
Top Healthcare Technology Stocks For 2014: Nabors Industries Ltd (NBI)
Nabors Industries Ltd. (Nabors), incorporated on December 11, 2001, is the land drilling contractor and land well-servicing and workover contractors in the United States and Canada. The Company markets approximately 474 land drilling rigs for oils and gas land drilling operations in the United States Lower 48 states, Alaska, Canada and over 20 other countries globally. The Company actively markets approximately 442 rigs for land well-servicing and workover work in the United States and approximately 106 rigs for land well-servicing and workover work in Canada. In 2012, the Company sold its remaining wholly-owned oil and gas business in Colombia and sold additional wholly owned assets in the United States. In April 2012, TransForce Inc. acquired through its subsidiary, I.E. Miller Services, Inc, certain assets of Peak USA Energy Services, Ltd., subsidiary of Nabors Industries Ltd. In December 2012, the Company sold its 49.7% ownership interest in NFR Energy LLC (NFR Energy).
The Company is a provider of offshore platform workover and drilling rigs, and actively markets 36 platform, 12 jackup and four barge rigs in the United States, including the Gulf of Mexico, and multiple international markets.The Company provides completion and production services, including hydraulic fracturing, cementing, nitrogen and acid pressures pumping services with over 805,000 hydraulic horsepower in United States and Canada. The Company offers a range of ancillary well-site services, including engineering, transportation and disposal, construction, maintenance, well logging, directional drilling, rigs instrumentation, data collection and other support services in select United States and international markets. The Company manufactures and lease or sell drives for a ranges of drilling applications, directional drilling systems, rig instrumentation and data collection equipment, pipeline handling equipment and rig reporting software. The Company has a 51% ownership interest in a joint venture in Saudi Arabia, w! hich owns and actively markets nine rigs in addition to the rigs the Company leases to the joint venture.
A land-based drilling rig generally consists of engines, a drawworks, a mast (or derrick), pumps to circulate drilling fluid under various pressures, blowout preventers, drill string and related equipment. Special-purpose drilling rigs used to perform workover services consist of a mobile carrier, which includes an engine, drawworks and a mast, together with other standard drilling accessories and specialized equipment for servicing wells. These rigs are specially designed for repairs and modifications of oil and gas wells, including standard drilling functions. Land-based drilling rigs are moved between well sites and among geographic areas using the Company's fleet of cranes, loaders and transport vehicles or those of third-party service providers.
Platform rigs provide offshore workover, drilling and re-entry services. The Company's platform rigs have drilling and/or well-servicing or workover equipment and machinery arranged in modular packages that are transported to, and assembled and installed on, fixed offshore platforms owned by the customer. Jackup rigs are mobile, self-elevating drilling and workover platforms equipped with legs that can be lowered to the ocean floor until a foundation is established to support the hull, which contains the drilling and/or workover equipment, jacking system, crew quarters, loading and unloading facilities, storage areas for bulk and liquid materials, helicopter landing deck and other related equipment. The Company also own two workover inland barge rigs. These barges are designed to perform plugging and abandonment, well-service or workover services in shallow inland, coastal or offshore waters.
The Company provides a range of wellsite solutions to oil and natural gases companies, consisting primarily of technical pumping services, including hydraulic fracturing, a process sometimes used in the completion of oil and g! as wells ! whereby water, sand and chemicals are injected under pressure into subsurface formations to stimulate gas and oil production, and down-hole surveying services. Other technical services include completion, production and rental tool services. In addition, the Company provides fluid logistics services, including those related to the transportation, storage and disposal of fluids that is used in the drilling, development and production of hydrocarbons.
The Company provides maintenance services on the mechanical apparatus used to pump or lift oils from producing wells. These services include, among other activities, repairing and replacing pumps, sucker rods and tubing. They also occasionally include drilling services. The Company provides the rigs, equipment and crews for these tasks, which are performed on both oil and natural gas wells, but which are more commonly required on oil wells. Producing oil and natural gas wells occasionally require repairs or modifications, called workovers. The Company can also provide other specialized services, including onsite temporary fluid storage; the supply, removal and disposal of specialized fluids used during certain completion and workover operations, and the removal and disposal of salt water that often accompanies the production of oil and natural gas.
Through various subsidiaries, the Company manufactures top drives and catwalks, which is installed on both onshore and offshore drilling rigs. The Company provides heavy equipment to move drilling rigs, water, other fluids and construction materials as well as the means to moves such equipment. The Company offers specialized drilling technologies, including patented steering systems and rigs instrumentation software systems, including ROCKITTM directional drilling system, which is used to provide data collection services to oil and gas exploration and service companies, and RIGWATCHTM software, which is computerized software and equipment that monitors a rig's real-time performance and da! ily repor! ting for drilling operations, making this data available through the Internet.
The Company competes with Helmerich and Payne, Inc., Patterson-UTI Energy, Inc., Basic Energy Services, Inc., Key Energy Services, Inc., Superior Energy Services, Inc., Forbes Energy Services Ltd., Halliburton, Baker Hughes, Weatherford International Ltd., Schlumberger Limited, FTS International Services LLC, C&J Energy Services, Inc. and RPC, Inc.Advisors' Opinion:
- [By Anora Mahmudova]
The Nasdaq Composite (COMP) �dropped 129.79 points, or 3.1%, its worst one-day percentage decline since November 2011. The Nasdaq Biotech index (NBI) � as well as iShares Nasdaq Biotechnology ETF (IBB) � dropped 5.6%.
Top Healthcare Technology Stocks For 2014: Orexigen Therapeutics Inc.(OREX)
Orexigen Therapeutics, Inc., a development stage company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed phase III clinical trials; and Empatic that has completed phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; and naltrexone is a treatment for alcohol and opioid addiction. The company?s Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide is for the adjunctive treatment of partial seizures, a form of epilepsy. The company has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave. Orexigen Therapeutics, Inc. was founded in 2002 and is based in La Jolla, California.Advisors' Opinion:
- [By Lee Jackson]
Orexigen Therapeutics Inc. (NASDAQ: OREX) is a very controversial name that may end up being the only obesity drug play that actually works well enough to move the stock price. Its drug Contrave was tested in four separate late-stage studies, of which the primary endpoint of achieving a 5% weight-loss in a pre-specified percentage of patients was reached each time. Merrill Lynch recommends Orexigen as a stock to buy and has a $10 price target. The consensus target is posted even higher at $12. The stock closed yesterday at $6.29.
- [By Brian Orelli]
Depending on how well VIVUS recovers from the turmoil, the proxy fight could even benefit Orexigen (NASDAQ: OREX ) , which has an obesity drug that could be on the market next year.
Top Healthcare Technology Stocks For 2014: Euro/Forint(GY)
GenCorp Inc. engages in the manufacture and sale of aerospace and defense products and systems in the United States. The company operates in two segments, Aerospace and Defense, and Real Estate. The Aerospace and Defense segment offers defense system products, including liquid, solid, and air-breathing propulsion systems and components for applications in missile defense systems, maneuvering propulsion systems, precision war-fighting systems, and specialty metal products, as well as for use in strategic, tactical, and precision strike missiles. This segment also provides composite and metallic aerospace structural components, and warhead and armament systems for precision tactical and long range weapon applications. In addition, it provides liquid, solid, and electric propulsion systems and components for space systems, such as expendable and reusable launch vehicles, transatmospheric vehicles, manned and unmanned spacecraft, separation and maneuvering systems, upper stage engines, satellites, solid boosters, and integrated propulsion subsystems. This segment serves military, civil, and commercial space customers; Department of Defense; National Aeronautics and Space Administration; aerospace, defense, and commercial prime contractors; and various agencies of the United States government. The Real Estate segment engages in the re-zoning, entitlement, sale, and leasing of the company?s excess real estate assets; and owns approximately 12,200 acres of land in the Sacramento metropolitan area. GenCorp Inc. was founded in 1915 and is headquartered in Rancho Cordova, California.Advisors' Opinion:
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of GenCorp (NYSE: GY) were down 5.16 percent to $17.64 after the company reported Q1 results. GenCorp reported a Q1 loss of $0.03 per share.
- [By Rich Smith]
GenCorp (NYSE: GY ) probably also comes to mind. It's hard to imagine a company with more of a 1950s space-frontier feel to it than the one that owns Rocketdyne -- a name that could have come straight out of a pulp Heinlein novel.
- [By Rick Munarriz]
The first trading day of the week kicks off with GenCorp (NYSE: GY ) posting quarterly results. The aerospace and defense contractor completed its acquisition of Pratt & Whitney's rocket engine manufacturer Rocketdyne after receiving clearance from the Federal Trade Commission earlier this month. Naturally, Rocketdyne's performance won't be baked into the financials.